Literature DB >> 11267951

Yield of mammography in selected patients age < or = 30 years.

P A Johnstone1, E M Moore, R Carrillo, C J Goepfert.   

Abstract

BACKGROUND: An outcomes analysis study was performed to quantify the benefit of directed diagnostic imaging of selected very young women (defined as < or = 30 years of age) in our population. Summary results are presented. PATIENTS AND METHODS: Women's Imaging Services were queried for studies performed between April 1, 1997 and December 31, 1998 on women < or = 30 years of age. The authors' referral pathway mandates breast examination by a general surgeon or by the head of Women's Imaging before mammography in all such patients. Studies were excluded if there were reviews of scans performed at other sites. The resulting 142 mammograms were evaluated.
RESULTS: Ninety percent of the 142 studies were within normal limits. Only 11 mammograms indicated any required action (7.8%), and only 5 of these merited biopsy. All biopsies revealed benign disease. No carcinomas were detected by biopsy or on clinical follow-up in this cohort of women. These values are congruent with the scarce literature on mammography in this population.
CONCLUSIONS: The yield of mammography in the age < or = 30 years population is low. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11267951     DOI: 10.1002/1097-0142(20010315)91:6<1075::aid-cncr1102>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

Authors:  Leslee J Shaw; Allen J Taylor; Patrick G O'Malley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

2.  Surgical mammography reporting in a limited resource environment.

Authors:  John P Mouton; Justus Apffelstaedt; Karin Baatjes
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

3.  Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.

Authors:  J-H Chen; R S Mehta; H-M Baek; K Nie; H Liu; M Q Lin; H J Yu; O Nalcioglu; M-Y Su
Journal:  NMR Biomed       Date:  2010-09-22       Impact factor: 4.044

4.  Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.

Authors:  G H de Bock; K M Vermeulen; L Jansen; J C Oosterwijk; S Siesling; M D Dorrius; T Feenstra; N Houssami; M J W Greuter
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.